{"id":15121,"date":"2012-07-19T16:30:00","date_gmt":"2012-07-19T14:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/abbott-laboratories-trimestrale-col-bicchiere-mezzo-vuoto\/"},"modified":"2012-07-19T16:30:00","modified_gmt":"2012-07-19T14:30:00","slug":"abbott-laboratories-trimestrale-col-bicchiere-mezzo-vuoto","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/abbott-laboratories-trimestrale-col-bicchiere-mezzo-vuoto\/","title":{"rendered":"Abbott Laboratories, Glass Half Empty Quarterly"},"content":{"rendered":"<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><span style=\"line-height: 115%; font-size: 12pt\"><font face=\"Calibri\">Light and Shadow Quarterly for Abbott Laboratories. <br \/> The US pharmaceutical company ended the second quarter with net income down by 11% to $1.73 billion, or $1.08 per share, compared to $1.94 billion ($1.23 per share) recorded during the same period last year. Excluding special items, Abbott&#039;s EPS came in at $1.23 per share, a cent above market expectations. <br \/> Also in the quarter, sales rose 2% to $9.81 billion, broadly in line with analyst estimates. <br \/> The outlook for the full year 2012 has been confirmed: earnings per share are expected in the range of 5-5.10 dollars.<br \/> Meanwhile, on the Nyse, Abbott shares are losing 0.62% to 66.05 dollars.<\/p>\n<p><\/font><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><em><span style=\"line-height: 115%; font-family: &quot;Verdana&quot;,&quot;sans-serif&quot;; color: #7a7a7a; font-size: 10pt\">July 18, 2012&nbsp;&nbsp; <img","protected":false},"excerpt":{"rendered":"<p>Trimestrale a luci e ombre per Abbott Laboratories. La compagnia farmaceutica statunitense ha chiuso il secondo trimestre con un utile netto in calo dell&#8217;11% a 1,73 miliardi di dollari, pari a 1,08 dollari per azione, rispetto agli 1,94 miliardi (1,23 dollari per azione) registrati nello stesso periodo dello scorso anno. Escluse le poste straordinarie, l&#8217;EPS &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-15121","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/15121","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=15121"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/15121\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=15121"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=15121"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=15121"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}